Page 53 - CIBERBBN-2015-eng

Research groups
Main lines of research
• Genetic therapy: - Development of technology for the detection of
- Genetic therapy directed for reprogramming cells in vivo and in vitro for the regeneration of the retina.
- Development of new nanoparticles to perform as vehicles for genes in genetic therapies.
• Development of biomedical technologies:
- Development of robots to assist in surgery and surgery simulations.
- Development of devices for neurorehabilitation and robot assisted rehabilitation.
- Development of non-invasive brain-computer interfaces (BCI) based on electroencephalogra- phy (EEG) electrooculography (EOG for disabled people.
breast cancer.
- Development of new generations of multifunc- tional intraocular lenses.
- Development of software for neural signal anal- ysis.
• Functional optimization and improvement of bio- compatibility of long term neural interfaces.
• Study of cortical reorganization and associated changes to neural plasticity in the blind.
Institution: Universidad Miguel Hernández · Contact: Instituto de Bioingeniería. Edificio Vinalopó. Avda. de la Universidad S/N. 03202 Elche · Tel.: 96 522 20 01· E.mail: [email protected] Website: http://nbio.umh.es/
CIBER-BBN I Annual report 2015 I 53